Titan Medical Inc. (TSX:TMD)
Canada
· Delayed Price · Currency is CAD 1.250
+0.125 (11.11%)
Inactive · Last trade price
on Oct 11, 2024
Titan Medical Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2014 - 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2014 - 2018 |
| Revenue | 0.45 | 17.63 | - | 20.09 | 20 | - | Upgrade
|
| Revenue Growth (YoY) | -97.38% | - | - | 0.47% | - | - | Upgrade
|
| Gross Profit | 0.45 | 17.63 | - | 20.09 | 20 | - | Upgrade
|
| Selling, General & Admin | 3.82 | 6.96 | 11.48 | 12.11 | 7.63 | 7.82 | Upgrade
|
| Research & Development | -0.59 | 0.32 | 33.01 | 38.22 | 7.94 | 51.42 | Upgrade
|
| Operating Expenses | 3.23 | 7.28 | 44.49 | 50.33 | 15.85 | 59.27 | Upgrade
|
| Operating Income | -2.78 | 10.36 | -44.49 | -30.24 | 4.15 | -59.27 | Upgrade
|
| Interest Expense | -0.15 | -0.22 | -0.15 | -0.19 | -1.09 | -0.42 | Upgrade
|
| Interest & Investment Income | 0.45 | 0.31 | 0.15 | 0.07 | 0.03 | 0.12 | Upgrade
|
| Currency Exchange Gain (Loss) | 0.01 | 0.03 | -0.06 | -0.13 | -0.11 | -0.04 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.15 | 0.48 | 4.56 | 16.36 | -29.67 | 17.7 | Upgrade
|
| EBT Excluding Unusual Items | -2.32 | 10.96 | -40 | -14.12 | -26.7 | -41.91 | Upgrade
|
| Gain (Loss) on Sale of Assets | 0.24 | 0.24 | - | - | - | - | Upgrade
|
| Asset Writedown | -1.99 | -1.99 | -2.32 | - | - | - | Upgrade
|
| Legal Settlements | - | - | - | - | 2.51 | - | Upgrade
|
| Other Unusual Items | -1.51 | -2.23 | -0.28 | -0.68 | - | - | Upgrade
|
| Pretax Income | -5.58 | 6.98 | -42.6 | -14.8 | -24.18 | -41.91 | Upgrade
|
| Income Tax Expense | 0.03 | 0.02 | -0.06 | 0.06 | - | - | Upgrade
|
| Net Income | -5.6 | 6.95 | -42.54 | -14.86 | -24.18 | -41.91 | Upgrade
|
| Net Income to Common | -5.6 | 6.95 | -42.54 | -14.86 | -24.18 | -41.91 | Upgrade
|
| Shares Outstanding (Basic) | 114 | 113 | 112 | 108 | 67 | 31 | Upgrade
|
| Shares Outstanding (Diluted) | 114 | 117 | 112 | 108 | 67 | 31 | Upgrade
|
| Shares Change (YoY) | 1.43% | 4.77% | 2.84% | 61.84% | 118.34% | 84.49% | Upgrade
|
| EPS (Basic) | -0.05 | 0.06 | -0.38 | -0.14 | -0.36 | -1.37 | Upgrade
|
| EPS (Diluted) | -0.05 | 0.06 | -0.38 | -0.14 | -0.36 | -1.37 | Upgrade
|
| Free Cash Flow | -6.26 | 4.68 | -28.28 | -36.99 | -1.13 | -45.96 | Upgrade
|
| Free Cash Flow Per Share | -0.06 | 0.04 | -0.25 | -0.34 | -0.02 | -1.50 | Upgrade
|
| Gross Margin | 100.00% | 100.00% | - | 100.00% | 100.00% | - | Upgrade
|
| Operating Margin | -617.56% | 58.73% | - | -150.49% | 20.76% | - | Upgrade
|
| Profit Margin | -1245.33% | 39.43% | - | -73.95% | -120.92% | - | Upgrade
|
| Free Cash Flow Margin | -1392.00% | 26.55% | - | -184.08% | -5.63% | - | Upgrade
|
| EBITDA | -2.57 | 10.54 | -44.03 | -29.84 | 4.33 | -59.24 | Upgrade
|
| EBITDA Margin | - | 59.78% | - | -148.52% | 21.64% | - | Upgrade
|
| D&A For EBITDA | 0.21 | 0.19 | 0.45 | 0.4 | 0.18 | 0.03 | Upgrade
|
| EBIT | -2.78 | 10.36 | -44.49 | -30.24 | 4.15 | -59.27 | Upgrade
|
| EBIT Margin | - | 58.73% | - | -150.49% | 20.76% | - | Upgrade
|
| Effective Tax Rate | - | 0.34% | - | - | - | - | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.